Skip to main content

LMR Partners LLP

Position in IBRX — ImmunityBio, Inc.

CIK 1578621 LONDON, X0

Position in IBRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
13 quarters on record

Derivatives in IBRX

reported options exposure · as of Jun 30, 2026
CallValue
$34,879,044
CallShares
3,983,900
PutValue
$2,285,930
PutShares
261,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in IBRX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $34,879,044 3,983,900
2026-06-30 $2,285,930 261,100
2026-03-31 $3,941,613 513,900
2026-03-31 $29,336,983 3,824,900
2025-12-31 $514,800 260,000
2025-09-30 $1,481,904 602,400
2025-06-30 $2,214,168 838,700
2025-03-31 $551,432 183,200
2024-12-31 $252,160 98,500
2024-12-31 $121,349 47,402
2024-09-30 $292,020 78,500
2024-06-30 $1,533,864 242,700
2024-03-31 $417,786 77,800
2023-12-31 $414,150 82,500
2023-09-30 $636,792 376,800
2023-06-30 $1,395,560 502,000